Cidara Therapeutics, Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
CDTX Company Description
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
CDTX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view CDTX Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of CDTX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CDTX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of CDTX in WallStreetBets Daily Discussion
CDTX News
Recent insights relating to CDTX
CNBC Recommendations
Recent picks made for CDTX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in CDTX
Corporate Flights
Flights by private jets registered to CDTX
Our Analysis